• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为PIM1抑制剂的氨基恶二唑衍生物的定量构效关系研究及基于质朴配体的虚拟筛选

QSAR study and rustic ligand-based virtual screening in a search for aminooxadiazole derivatives as PIM1 inhibitors.

作者信息

Aouidate Adnane, Ghaleb Adib, Ghamali Mounir, Chtita Samir, Ousaa Abdellah, Choukrad M'barek, Sbai Abdelouahid, Bouachrine Mohammed, Lakhlifi Tahar

机构信息

MCNSL, School of Sciences, Moulay Ismail University, Meknes, Morocco.

High School of Technology, Moulay Ismail University, Meknes, Morocco.

出版信息

Chem Cent J. 2018 Mar 22;12(1):32. doi: 10.1186/s13065-018-0401-x.

DOI:10.1186/s13065-018-0401-x
PMID:29564572
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5862716/
Abstract

BACKGROUND

Quantitative structure-activity relationship (QSAR) was carried out to study a series of aminooxadiazoles as PIM1 inhibitors having pk ranging from 5.59 to 9.62 (k in nM). The present study was performed using Genetic Algorithm method of variable selection (GFA), multiple linear regression analysis (MLR) and non-linear multiple regression analysis (MNLR) to build unambiguous QSAR models of 34 substituted aminooxadiazoles toward PIM1 inhibitory activity based on topological descriptors.

RESULTS

Results showed that the MLR and MNLR predict activity in a satisfactory manner. We concluded that both models provide a high agreement between the predicted and observed values of PIM1 inhibitory activity. Also, they exhibit good stability towards data variations for the validation methods. Furthermore, based on the similarity principle we performed a database screening to identify putative PIM1 candidates inhibitors, and predict their inhibitory activities using the proposed MLR model.

CONCLUSIONS

This approach can be easily handled by chemists, to distinguish, which ones among the future designed aminooxadiazoles structures could be lead-like and those that couldn't be, thus, they can be eliminated in the early stages of drug discovery process.

摘要

背景

开展定量构效关系(QSAR)研究,以考察一系列氨基恶二唑作为PIM1抑制剂的情况,其pK值范围为5.59至9.62(k以nM计)。本研究采用遗传算法变量选择(GFA)、多元线性回归分析(MLR)和非线性多元回归分析(MNLR),基于拓扑描述符构建34种取代氨基恶二唑对PIM1抑制活性的明确QSAR模型。

结果

结果表明,MLR和MNLR对活性的预测效果良好。我们得出结论,这两个模型在PIM1抑制活性的预测值和观测值之间具有高度一致性。此外,对于验证方法,它们对数据变化表现出良好的稳定性。此外,基于相似性原理,我们进行了数据库筛选,以识别潜在的PIM1候选抑制剂,并使用所提出的MLR模型预测它们的抑制活性。

结论

这种方法化学家可以轻松掌握,以区分未来设计的氨基恶二唑结构中哪些可能具有类先导物性质,哪些不具有,从而在药物发现过程的早期阶段将它们排除。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f607/5862716/adaaaee1204b/13065_2018_401_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f607/5862716/31275b67031a/13065_2018_401_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f607/5862716/c66733829006/13065_2018_401_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f607/5862716/384a64acbb94/13065_2018_401_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f607/5862716/607fcffa91e0/13065_2018_401_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f607/5862716/aee6c119d712/13065_2018_401_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f607/5862716/adaaaee1204b/13065_2018_401_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f607/5862716/31275b67031a/13065_2018_401_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f607/5862716/c66733829006/13065_2018_401_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f607/5862716/384a64acbb94/13065_2018_401_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f607/5862716/607fcffa91e0/13065_2018_401_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f607/5862716/aee6c119d712/13065_2018_401_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f607/5862716/adaaaee1204b/13065_2018_401_Fig6_HTML.jpg

相似文献

1
QSAR study and rustic ligand-based virtual screening in a search for aminooxadiazole derivatives as PIM1 inhibitors.作为PIM1抑制剂的氨基恶二唑衍生物的定量构效关系研究及基于质朴配体的虚拟筛选
Chem Cent J. 2018 Mar 22;12(1):32. doi: 10.1186/s13065-018-0401-x.
2
QSAR studies on PIM1 and PIM2 inhibitors using statistical methods: a rustic strategy to screen for 5-(1H-indol-5-yl)-1,3,4-thiadiazol analogues and predict their PIM inhibitory activity.使用统计方法对PIM1和PIM2抑制剂进行定量构效关系研究:一种筛选5-(1H-吲哚-5-基)-1,3,4-噻二唑类似物并预测其PIM抑制活性的质朴策略。
Chem Cent J. 2017 May 19;11(1):41. doi: 10.1186/s13065-017-0269-1.
3
3D QSAR studies, molecular docking and ADMET evaluation, using thiazolidine derivatives as template to obtain new inhibitors of PIM1 kinase.基于噻唑烷衍生物模板的 3D QSAR 研究、分子对接和 ADMET 评估,以获得新的 PIM1 激酶抑制剂。
Comput Biol Chem. 2018 Jun;74:201-211. doi: 10.1016/j.compbiolchem.2018.03.008. Epub 2018 Mar 12.
4
Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents.遗传算法-多元线性回归在作为抗癌剂的芳基硫代吲哚类微管蛋白聚合抑制剂定量构效关系建模中的应用。
Anticancer Agents Med Chem. 2017;17(4):552-565. doi: 10.2174/1871520616666160811162105.
5
Development of linear and nonlinear predictive QSAR models and their external validation using molecular similarity principle for anti-HIV indolyl aryl sulfones.基于分子相似性原理的抗HIV吲哚基芳基砜类线性和非线性预测QSAR模型的构建及其外部验证
J Enzyme Inhib Med Chem. 2008 Dec;23(6):980-95. doi: 10.1080/14756360701811379.
6
Comparative chemometric modeling of cytochrome 3A4 inhibitory activity of structurally diverse compounds using stepwise MLR, FA-MLR, PLS, GFA, G/PLS and ANN techniques.使用逐步多元线性回归(MLR)、因子分析多元线性回归(FA-MLR)、偏最小二乘法(PLS)、广义因子分析(GFA)、广义偏最小二乘法(G/PLS)和人工神经网络(ANN)技术对结构多样的化合物的细胞色素3A4抑制活性进行比较化学计量学建模。
Eur J Med Chem. 2009 Jul;44(7):2913-22. doi: 10.1016/j.ejmech.2008.12.004. Epub 2008 Dec 16.
7
2D QSAR and Virtual Screening based on Pyridopyrimidine Analogs of Epidermal Growth Factor Receptor Tyrosine Kinase.基于表皮生长因子受体酪氨酸激酶的吡啶并嘧啶类似物的二维定量构效关系和虚拟筛选
Curr Comput Aided Drug Des. 2016;12(3):229-240. doi: 10.2174/1573409912666160606150323.
8
Genetic Algorithm and Self-Organizing Maps for QSPR Study of Some N-aryl Derivatives as Butyrylcholinesterase Inhibitors.用于某些N-芳基衍生物作为丁酰胆碱酯酶抑制剂的定量构效关系研究的遗传算法和自组织映射
Curr Drug Discov Technol. 2016;13(4):232-253. doi: 10.2174/1570163813666160725114241.
9
QSAR Modeling of the Arylthioindole Class of Colchicine Polymerization Inhibitors as Anticancer Agents.秋水仙碱聚合抑制剂类芳基硫代吲哚作为抗癌剂的定量构效关系建模
Curr Comput Aided Drug Des. 2017;13(2):143-159. doi: 10.2174/1573409913666170124100810.
10
Quantitative Structure-Activity Relationship Study of Camptothecin Derivatives as Anticancer Drugs Using Molecular Descriptors.基于分子描述符的喜树碱衍生物作为抗癌药物的定量构效关系研究
Comb Chem High Throughput Screen. 2019;22(6):387-399. doi: 10.2174/1386207322666190708112251.

引用本文的文献

1
Activity prediction, structure-based drug design, molecular docking, and pharmacokinetic studies of 1,4-dihydropyridines derivatives as α-amylase inhibitors.1,4-二氢吡啶衍生物作为α-淀粉酶抑制剂的活性预测、基于结构的药物设计、分子对接及药代动力学研究
J Taibah Univ Med Sci. 2023 Dec 22;19(2):270-286. doi: 10.1016/j.jtumed.2023.12.003. eCollection 2024 Apr.
2
Insights into the medicinal chemistry of heterocycles integrated with a pyrazolo[1,5-]pyrimidine scaffold.关于与吡唑并[1,5 -]嘧啶骨架整合的杂环药物化学的见解。
RSC Med Chem. 2022 Sep 8;13(10):1150-1196. doi: 10.1039/d2md00192f. eCollection 2022 Oct 19.
3

本文引用的文献

1
Thiazolidine derivatives as potent and selective inhibitors of the PIM kinase family.噻唑烷衍生物作为PIM激酶家族的强效和选择性抑制剂。
Bioorg Med Chem. 2017 May 1;25(9):2657-2665. doi: 10.1016/j.bmc.2017.02.056. Epub 2017 Feb 28.
2
Discovery of 5-(1H-indol-5-yl)-1,3,4-thiadiazol-2-amines as potent PIM inhibitors.发现5-(1H-吲哚-5-基)-1,3,4-噻二唑-2-胺作为有效的PIM抑制剂。
Bioorg Med Chem Lett. 2015 Feb 15;25(4):775-80. doi: 10.1016/j.bmcl.2014.12.091. Epub 2015 Jan 7.
3
The discovery and optimization of aminooxadiazoles as potent Pim kinase inhibitors.
Comparison of various methods for validity evaluation of QSAR models.
定量构效关系(QSAR)模型有效性评估的各种方法比较。
BMC Chem. 2022 Aug 23;16(1):63. doi: 10.1186/s13065-022-00856-4.
4
Identification of a novel dual-target scaffold for 3CLpro and RdRp proteins of SARS-CoV-2 using 3D-similarity search, molecular docking, molecular dynamics and ADMET evaluation.利用 3D 相似性搜索、分子对接、分子动力学和 ADMET 评估鉴定新型 SARS-CoV-2 3CLpro 和 RdRp 双靶标支架。
J Biomol Struct Dyn. 2021 Aug;39(12):4522-4535. doi: 10.1080/07391102.2020.1779130. Epub 2020 Jun 18.
5
Development of QSAR machine learning-based models to forecast the effect of substances on malignant melanoma cells.基于定量构效关系(QSAR)机器学习模型预测物质对恶性黑色素瘤细胞影响的研究进展
Oncol Lett. 2019 May;17(5):4188-4196. doi: 10.3892/ol.2019.10068. Epub 2019 Feb 25.
作为强效Pim激酶抑制剂的氨基恶二唑的发现与优化。
Bioorg Med Chem Lett. 2015 Feb 15;25(4):847-55. doi: 10.1016/j.bmcl.2014.12.067. Epub 2015 Jan 7.
4
Lead- and drug-like compounds: the rule-of-five revolution.类铅化合物和类药物化合物:五规则革命
Drug Discov Today Technol. 2004 Dec;1(4):337-41. doi: 10.1016/j.ddtec.2004.11.007.
5
AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia.AZD1208,一种强效和选择性的全 Pim 激酶抑制剂,在急性髓系白血病的临床前模型中显示出疗效。
Blood. 2014 Feb 6;123(6):905-13. doi: 10.1182/blood-2013-04-495366. Epub 2013 Dec 20.
6
QSAR modeling: where have you been? Where are you going to?定量构效关系模型:你从何处来?你将往何处去?
J Med Chem. 2014 Jun 26;57(12):4977-5010. doi: 10.1021/jm4004285. Epub 2014 Jan 6.
7
Computational elucidation of structural basis for ligand binding with Leishmania donovani adenosine kinase.计算阐明利什曼原虫腺苷激酶与配体结合的结构基础。
Biomed Res Int. 2013;2013:609289. doi: 10.1155/2013/609289. Epub 2013 Jul 24.
8
Targeting Pim-1 kinase for potential drug-development.靶向Pim-1激酶用于潜在的药物开发。
Int J Comput Biol Drug Des. 2012;5(2):137-51. doi: 10.1504/IJCBDD.2012.048303. Epub 2012 Jul 31.
9
Mechanisms of cytotoxicity to Pim kinase inhibitor, SGI-1776, in acute myeloid leukemia.Pim 激酶抑制剂 SGI-1776 对急性髓系白血病细胞的细胞毒性作用机制。
Blood. 2011 Jul 21;118(3):693-702. doi: 10.1182/blood-2010-12-323022. Epub 2011 May 31.
10
PaDEL-descriptor: an open source software to calculate molecular descriptors and fingerprints.PaDEL-descriptor:一个开源软件,可用于计算分子描述符和指纹。
J Comput Chem. 2011 May;32(7):1466-74. doi: 10.1002/jcc.21707. Epub 2010 Dec 17.